These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12397691)

  • 1. [Preventing effect of angiotensin II receptor blocker on neointimal hyperplasia after vascular injury].
    Miyata M; Eto H; Biro S; Tei C
    Nihon Rinsho; 2002 Oct; 60(10):1957-61. PubMed ID: 12397691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation.
    Radke PW; Figulla HR; Drexler H; Klues HG; Mügge A; Silber S; Daniel W; Schmeisser A; Reifart N; Motz W; Büttner HJ; Fischer D; Ortlepp JR; Schaefers K; Hoffmann R; Hanrath P;
    Am Heart J; 2006 Oct; 152(4):761.e1-6. PubMed ID: 16996855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin II and angiotensin II type 1 receptor blockade on neointimal formation after stent implantation.
    Groenewegen HC; van der Harst P; Roks AJ; Buikema H; Zijlstra F; van Gilst WH; de Smet BJ
    Int J Cardiol; 2008 May; 126(2):209-15. PubMed ID: 17482691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary stenting with a novel stainless steel balloon-expandable stent: determinants of neointimal formation and changes in arterial geometry after placement in an atherosclerotic model.
    Carter AJ; Laird JR; Kufs WM; Bailey L; Hoopes TG; Reeves T; Farb A; Virmani R
    J Am Coll Cardiol; 1996 Apr; 27(5):1270-7. PubMed ID: 8609355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can angiotensin receptor antagonists prevent restenosis after stent placement?
    Peters S
    Am J Cardiovasc Drugs; 2002; 2(3):143-8. PubMed ID: 14727976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of coronary artery restenosis.
    Schwartz RS; Henry TD
    Rev Cardiovasc Med; 2002; 3 Suppl 5():S4-9. PubMed ID: 12478229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the pig coronary artery injury model: comparison of plain old balloon angioplasty and stent implantation].
    Shimizu N; Suzuki H; Wakabayashi K; Iso Y; Shibata M; Yorozuya M; Katagiri T; Takeyama Y
    J Cardiol; 2004 Mar; 43(3):131-9. PubMed ID: 15067801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
    Gross CM; Perrot A; Geier C; Posch MG; Hassfeld S; Kramer J; Schmidt S; Derer W; Dietz R; Ozcelik C
    J Invasive Cardiol; 2007 Jun; 19(6):261-4. PubMed ID: 17541127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
    Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer stent coating for prevention of neointimal hyperplasia.
    Billinger M; Buddeberg F; Hubbell JA; Elbert DL; Schaffner T; Mettler D; Windecker S; Meier B; Hess OM
    J Invasive Cardiol; 2006 Sep; 18(9):423-6; discussion 427. PubMed ID: 16954581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study.
    Takagi T; Yamamuro A; Tamita K; Yamabe K; Katayama M; Mizoguchi S; Ibuki M; Tani T; Tanabe K; Nagai K; Shiratori K; Morioka S; Yoshikawa J
    Am Heart J; 2003 Aug; 146(2):E5. PubMed ID: 12891212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury.
    Moon MC; Molnar K; Yau L; Zahradka P
    J Vasc Surg; 2004 Jul; 40(1):130-7. PubMed ID: 15218473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of endothelin ETB receptor system aggravates neointimal hyperplasia after balloon injury of rat carotid artery.
    Kitada K; Yui N; Matsumoto C; Mori T; Ohkita M; Matsumura Y
    J Pharmacol Exp Ther; 2009 Dec; 331(3):998-1004. PubMed ID: 19737855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus eluting stent in the treatment of atherosclerosis coronary artery disease.
    Degertekin M; Regar E; Tanabe K; Lee CH; Serruys PW
    Minerva Cardioangiol; 2002 Oct; 50(5):405-18. PubMed ID: 12384623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
    Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury.
    Scott NA
    Adv Drug Deliv Rev; 2006 Jun; 58(3):358-76. PubMed ID: 16733073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfection of the DNA for the receptor KDR/flk-1 attenuates neointimal proliferation and luminal narrowing in a coronary stent angioplasty model.
    Buchwald AB; Kunze C; Waltenberger J; Unterberg-Buchwald C
    J Surg Res; 2006 Nov; 136(1):120-4. PubMed ID: 16979662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of local heating on restenosis and in-stent neointimal hyperplasia in the atherosclerotic rabbit model: a dose-ranging study.
    Brasselet C; Durand E; Addad F; Vitry F; Chatellier G; Demerens C; Lemitre M; Garnotel R; Urbain D; Bruneval P; Lafont A
    Eur Heart J; 2008 Feb; 29(3):402-12. PubMed ID: 18212388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neointimal hyperplasia inhibition effect of angiotensin II type 1 receptor blockers in patients after coronary stent implantation: a meta-analysis.
    Kun X; Yong L; Bo J; Hai-Ming S
    Am J Cardiovasc Drugs; 2011 Jun; 11(3):209-13. PubMed ID: 21619384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-receptor blockers: revival of the systemic prevention of restenosis?
    Wilensky RL
    Cardiovasc Drugs Ther; 2003 Jan; 17(1):63-73. PubMed ID: 12843688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.